Therapeutics: Vascular endothelial growth factor receptor 2 (VEGFR-2; KDR/Flk-1)

In vitro and rodent studies identified oral VEGFR-2 inhibitors that could help treat CNV. Chemical synthesis and in vitro testing of monocyclic pyrimidine analogs identified three compounds that inhib...